Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. EOSE
3. DLR
4. AVAV
5. MU
6. VSH
7. NVDA
8. ENPH
9. AAPL
10. BAC

Go back to Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting
(NASDAQ: CRDF) Delayed: 1.27 --0 (-0%)
Previous Close $1.27    52 Week High $ 
Open $1.26    52 Week Low $ 
Day High $1.29    P/E N/A 
Day Low $1.26    EPS $ 
Volume 202,657